200 million funds in the last four minutes of crazy crash plate, after six consecutive rises, this bull stock end dive

category:Finance
 200 million funds in the last four minutes of crazy crash plate, after six consecutive rises, this bull stock end dive


Data source: wind

Stronger pharmaceutical sector

Among the 18 industries that fell, nonferrous metals, mining, and defense and military industries ranked first, down 2.93%, 2.16% and 1.99% respectively. At the same time, the non bank financial and banking industries, which recently led the market to attack, adjusted again today, falling 0.29% and 0.15% respectively.

Data source: wind

The pharmaceutical and biological industry rose by 2.20% today, with the trading limits of Shanhe Yaofu, Qizheng Tibetan medicine, Zhengchuan shares, jianzhijia, Tonghua Jinma and Tibet pharmaceutical.

From the perspective of the contribution to gem, Aier Ophthalmology, Watson biology and Zhifei biology, which rank the top in the gem contribution, belong to the pharmaceutical biology sector. Among the top 10 stocks contributing to the gem, only Dongfang fortune and Ningde era do not belong to the pharmaceutical and biological sector, while the other 8 stocks belong to the pharmaceutical and biological sector. It can be seen that the pharmaceutical shares have a boosting effect on the gem.

Data source: tongdaxin

After continuous adjustment before this, the pharmaceutical and biological sector began to strengthen in the past five trading days. The shenwanwan pharmaceutical and biological industry index rose by 5.26%, ranking first in the industry growth list.

For the pharmaceutical and biological sector, Societe Generale Securities said that from the perspective of investment layout, it reviewed the situation of the pharmaceutical sector and related companies during the first round of centralized drug procurement (4 + 7) in 2018. After the middle of 2018, a number of event factors superimposed on the expectation of drug centralized purchase, and the pharmaceutical sector began to show an obvious correction. The time point after the implementation of 4 + 7 pharmaceutical centralized purchase in 2018 is a better time point for investment layout after valuation correction of pharmaceutical sector, especially for the head innovative companies in the pharmaceutical sector. The medical device sector will gradually move towards innovation in the future, and the innovation leader is expected to copy the trend of the innovative medicine plate company in 2019.

Guosheng financial holding, a leading stock of securities companies

When the pharmaceutical and biological sector was stronger, the major financial sector, which recently led the Shanghai Composite Index to break through 3458, adjusted again today. The wind securities index rose 0.15%, and the wind bank index and wind insurance index fell 0.21% and 0.88% respectively.

It is worth noting that Guosheng financial holding, the leading stock in the securities trading plate, was trading at the end of the day when it was hit by large orders and closed up 6.61%. Guohai Securities touched trading limits, up 4.04% as of the close.

When the trading limit was broken at the end of todays trading, judging from the transaction details, there was fierce competition for long and short funds. From 14:56:12, there were large orders selling at the limit price. At 14:56:12 and 14:56:18, more than 20000 large orders were sold at the limit price, while Guosheng financial holding was broken open at 14:56:21, and 18000 hands were sold at the price of 16.35 yuan. From 14:56:30, more than 1000 orders were successively paid. Finally, at 14:56:48, Guosheng Financial Holdings Limited closed the trading limit, and more than 6000 orders were traded in the trading houses, and then continued to pay orders. At the time of call auction, 42000 orders were traded at the price of 15.97 yuan. At the end of the day, there were 4814 orders for 15.97 yuan.

According to the open trading information of Shenzhen Stock Exchange on December 3, Guosheng Financial Holding Co., Ltd. was listed on the dragon and tiger list due to the accumulative 20% deviation of closing price rise in three consecutive trading days. The dragon and tiger list released the data from December 1 to December 3.

According to the data of the dragon and tiger list, there are many powerful hot money in the list. One is industrial securities Shaanxi Branch. The seat was bought 130 million yuan, sold 56.6064 million yuan, and the net purchase amount was 73.3813 million yuan. The second buyer was Guotai Junan Securities Shanghai Jiangsu Road business department, which bought 94.7386 million yuan and sold 55.2794 million yuan. The net purchase amount was 39.4592 million yuan. Shaoxing securities business department of China Galaxy Securities purchased 87.6845 million yuan, sold 105 million yuan, and sold 17.1039 million yuan.

Among the top three sellers, Everbright Securities, Foshan Shunde Beijiao Yifu Road Securities Business Department, sold 327 million yuan, Guosheng securities, Nanchang Xiangshan South Road Securities Business Department, sold 157 million yuan, Guangfa Securities, Foshan Shunde Nanguo East Road Securities Business Department, sold 118 million yuan.

Data source: Dongfang fortune

For such a dragon and tiger list, guoshengjin holding bar investors are not optimistic, some investors said: industrial securities Shaanxi Branch, Guotai Junan Securities Shanghai Jiangsu Road business department, China Galaxy Securities Shaoxing securities business department three strength hot money are sold, tomorrow is dangerous.

Data source: Dongfang fortune

In addition to Guosheng financial holding, the bank shares of Zhengzhou bank were close to explosion board in late trading, with only 12000 hands left on the limit board.

Return of net inflow of funds to the North

Data source: wind

As for the reasons for the recent large inflow of foreign capital, Guosheng Securities said that the appreciation of RMB and the rebound of global stock markets have created good external conditions.

For the current market, Huaxin Securities said that, overall, the uncertainty of short-term emotional game is increasing, and it is safer for investors to choose low-priced mode. A-share has entered the time window of breakthrough. Once new trend can not be launched, the market will probably return to the box center. Southwest Securities said that at present, a shares are in the middle of the third bull market in history. Although the market will have a callback, but we should cherish the opportunity to get on the way up. The economic recovery is continuing, and the market will get better at the end of the year; there are opportunities for cycle growth, and the market is expected to reach 4000 points. CITIC Securities said that a shares are in a cross year cycle of slow growth. In the future, new overseas easing measures are expected to boost the global risk appetite. The domestic economy will continue to be stable and sound, and the policy will remain stable. It is expected that the behavior of institutional position adjustment at the end of the year will promote the pro cyclical plate market to continue to the first quarter of next year. Editor: Peng Yong, Zheng Yasuo source: China Securities Journal Author: Wu Yuhua, editor in charge: Zhong Qiming_ NF5619

For the current market, Huaxin Securities said that, overall, the uncertainty of short-term emotional game is increasing, and it is safer for investors to choose low-priced mode. A-share has entered the time window of breakthrough. Once new trend can not be launched, the market will probably return to the box center.

Southwest Securities said that at present, a shares are in the middle of the third bull market in history. Although the market will have a callback, but we should cherish the opportunity to get on the way up. The economic recovery is continuing, and the market will get better at the end of the year; there are opportunities for cycle growth, and the market is expected to reach 4000 points.

CITIC Securities said that a shares are in a cross year cycle of slow growth. In the future, new overseas easing measures are expected to boost the global risk appetite. The domestic economy will continue to be stable and sound, and the policy will remain stable. It is expected that the behavior of institutional position adjustment at the end of the year will promote the pro cyclical plate market to continue to the first quarter of next year.